RN Mobile Menu

Search form


Aisha T. Langford, PhD, MPH

Aisha T. Langford, PhD, MPH

Aisha T. Langford, PhD, MPH, is a freelance writer, speaker and academic researcher. She holds an appointment with the NYU School of Medicine as an assistant professor. Her research focuses on how health communication can improve individual medical decision making and reduce population health disparities in the context of clinical trial participation and chronic disease prevention. Dr. Langford holds a BA in English from the University of Virginia, an MPH in behavioral science and epidemiology from Saint Louis University School of Public Health, and a Ph.D. in health behavior and health education from the University of Michigan School of Public Health. 

Posts by Author

Baricitinib janus kinase inhibitor drug molecule. (Molekuul_be/Shutterstock.com)

Compared to placebo and adalimumab, the addition of once-daily oral baricitinib produced significant clinical improvements in RA patients, research shows.

(Combination medications  ©piotr_pabijan/Shutterstock.com)

Rheumatoid arthritis patients who fail previous methotrexate therapy respond better to TNFi–methotrexate combo, compared to a specific triple therapy, researchers say.

(Vaccinese ©adamgregor/Shutterstock.com)

The 23-valent pneumococcal polysaccharide vaccine (PPSV23) does not prevent pneumonia in rheumatoid arthritis patients, a new study finds.

(Foot with gout. ©joloei/Shutterstock.com)

For gout patients with suboptimal responses to allopurinol, adding lesinurad may significantly reduce serum urate levels.


Biologics dose individualization should be used more often in clinical practice due to its direct benefit for patients with rheumatoid arthritis, researchers recommend.

Parasite tick (©SergeyToronto/Shutterstock.com)

The authors of a small study that assesses treatment options after a Lyme disease infection, question the value of delaying treatment with disease-modifying anti-rheumatic drugs once autoimmune joint disorders set in.

(Synovial joint anatomy abstract. ©Tefi/Shutterstock.com)

Approximately one percent of the general population carries the auto-antibodies associated with rheumatoid arthritis, a new study shows.

(Increased Cardiovascular Risk ©Arka38/Shutterstock.com)

Patients with inflammatory arthritis are being treated for cardiovascular risk factors at rates similar to that of the general population, even though their risk is higher, study shows.

(Plantar fascia ©MedicalArtInc/Shutterstock.com)

Clinical enthesitis is a common condition for some psoriatic arthritis patients who are disproportionately affected by inflammation, particularly of the Achilles tendon, plantar fascia and lateral epicondyle.

(Anatomy of Human Heart ©LiyaGraphics/Shutterstock.com)

Myocardial inflammation/fibrosis has been identified in a study of rheumatoid arthritis patients with no known history of heart disease.


By clicking Accept, you agree to become a member of the UBM Medica Community.